Medical and Hospital News
INTERN DAILY
Novo Nordisk's obesity drug Wegovy goes on sale in China
Reuters Events SMR and Advanced Reactor 2025
Novo Nordisk's obesity drug Wegovy goes on sale in China
by AFP Staff Writers
Beijing (AFP) Nov 19, 2024

Novo Nordisk's blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday, as the Asian nation battles high rates of obesity.

The Danish pharmaceutical firm is the maker of two game-changing treatments for diabetes and obesity -- Ozempic and Wegovy -- propelling its emergence as Europe's most valuable company.

Wegovy was approved for use in China in June, and local media reported that the first prescription at a public hospital was issued in Shanghai on Monday.

A Novo Nordisk spokesperson confirmed to AFP on Tuesday that the drug was "now available in China" for the treatment of adults with obesity and those overweight with at least one weight-related comorbidity.

China's rapid economic development has driven health improvements in recent decades but that growth was also accompanied by an explosion in weight-related disorders.

Nearly half of all adults in the country are either overweight or obese, according to a peer-reviewed study last year that was covered by state media.

Local media reported that a month's supply of Wegovy will cost around 1,400 yuan ($193), compared to the reported US list price of $1,349.

Novo Nordisk last week posted a 21 percent rise in net profit to 27.3 billion kroner ($3.94 billion) in the third quarter, despite production constraints.

The company said it expected full-year sales to rise by 23 to 27 percent from a year earlier, revising its earlier forecast of 22 to 28 percent.

Related Links
Hospital and Medical News at InternDaily.com

Subscribe Free To Our Daily Newsletters
Tweet

RELATED CONTENT
The following news reports may link to other Space Media Network websites.
INTERN DAILY
Pharma giant AstraZeneca takes China probes 'very seriously'
London (AFP) Nov 12, 2024
British pharmaceutical giant AstraZeneca on Tuesday said it takes "very seriously" China's investigations into potential illegal data collection and drug imports by the group that led to the detention of its China boss. "We take the matters in China very seriously," chief executive Pascal Soriot said in a statement contained in the group's latest earnings release that revealed a small rise in net profit. "If requested we will fully cooperate with the authorities. We remain committed to deliver ... read more

INTERN DAILY
LIST and UNHCR partner to develop emergency early warning system

Senegal navy intercepts almost 1,000 illegal migrants in one month

Americans face an insurability crisis as climate change worsens disasters

Spain royals cheered in flood epicentre after chaotic trip

INTERN DAILY
Space Systems Command and U.S. Navy achieve major MGUE program milestone

N. Korea jams GPS signals, affecting ships, aircraft in South

Successful demo showcases BAE Systems' next-gen M-Code GNSS technology

BeiDou remote sensing experiment enhances ecological monitoring in Yellow River

INTERN DAILY
Sitting for extended periods linked to higher cardiovascular risk even in physically active individuals

Iraq holds its first census in nearly 40 years

Swedish app aims to solve household chore disputes

Study shows ancient use of fire to manage Tasmania's environment 41,600 years ago

INTERN DAILY
COP16 biodiversity finance deal for 'early 2025': presidency

'Critically endangered' African penguins just want peace and food

Fifty years of data reveal significant African elephant population declines

Bees help tackle elephant-human conflict in Kenya

INTERN DAILY
Fifth of dengue cases due to climate change: researchers

Spread of dengue fever in Bangladesh worries medics

Climate shifts and urbanisation drive Nepal dengue surge

Covid lessons learned? UN summit mulls plan for healthy planet, and humans

INTERN DAILY
Eight dead, 17 hurt, in China school knife attack; Police formally arrest car ramming suspect

China battles rare wave of violent crime as economic woes bite

China clears memorial to victims of deadly car ramming attack

China removes memorials to victims of deadliest attack in a decade

INTERN DAILY
El Salvador troops target gangs in large-scale operation

Hungary's Orban says corks will pop if Trump wins US election

INTERN DAILY
Subscribe Free To Our Daily Newsletters




The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.